De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Terumo Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Terumo heeft een totaal eigen vermogen van ¥1,418.5B en een totale schuld van ¥194.8B, wat de schuld-eigenvermogensverhouding op 13.7% brengt. De totale activa en totale passiva bedragen respectievelijk ¥1,869.0B en ¥450.5B. De EBIT Terumo is ¥155.6B waardoor de rentedekking -123.8 is. Het heeft contanten en kortetermijnbeleggingen van ¥194.9B.

Belangrijke informatie

13.7%

Verhouding schuld/eigen vermogen

JP¥194.79b

Schuld

Rente dekkingsratio	-123.8x
Contant	JP¥194.91b
Aandelen	JP¥1.42t
Totaal verplichtingen	JP¥450.50b
Totaal activa	JP¥1.87t

Recente financiële gezondheidsupdates

Terumo (TSE:4543) Has A Pretty Healthy Balance Sheet

Jul 05

Is Terumo (TSE:4543) Using Too Much Debt?

Feb 29

Recent updates

Estimating The Fair Value Of Terumo Corporation (TSE:4543)

Sep 16

Terumo Corporation Just Beat EPS By 12%: Here's What Analysts Think Will Happen Next

Aug 11

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( ¥708.8B ) 4543 } overtreffen de korte termijn passiva ( ¥237.8B ).

Langlopende schulden: De kortetermijnactiva 4543 ( ¥708.8B ) overtreffen de langetermijnschulden ( ¥212.7B ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: 4543 heeft meer geld in kas dan de totale schuld.

Schuld verminderen: De schuld/eigen vermogen-ratio van 4543 is de afgelopen 5 jaar gedaald van 32.1% naar 13.7%.

Schuldendekking: De schuld van 4543 wordt goed gedekt door de operationele kasstroom ( 87.6% ).

Rentedekking: 4543 verdient meer rente dan het betaalt, dus de dekking van rentebetalingen is geen probleem.

Terumo Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Terumo (TSE:4543) Has A Pretty Healthy Balance Sheet

Is Terumo (TSE:4543) Using Too Much Debt?

Recent updates

Terumo Corporation to Report Q2, 2025 Results on Nov 07, 2024

Upcoming dividend of JP¥13.00 per share

Estimating The Fair Value Of Terumo Corporation (TSE:4543)

Terumo Corporation (TSE:4543) announces an Equity Buyback for 15,000,000 shares, representing 1.01% for ¥30,000 million.

Terumo Corporation Just Beat EPS By 12%: Here's What Analysts Think Will Happen Next

First quarter 2025 earnings: EPS and revenues exceed analyst expectations

Investor sentiment deteriorates as stock falls 22%

Now 22% undervalued after recent price drop

Investors Still Waiting For A Pull Back In Terumo Corporation (TSE:4543)

Final dividend of JP¥13.00 announced

Full year 2024 earnings: EPS in line with analyst expectations despite revenue beat

Terumo (TSE:4543) Has A Pretty Healthy Balance Sheet

Less than half of directors are independent

Return Trends At Terumo (TSE:4543) Aren't Appealing

Now 20% overvalued

Terumo Corporation to Report Q1, 2025 Results on Aug 08, 2024

Terumo Cardiovascular Announces 510(K) Clearance for the CDI Oneview™? Monitoring System

Full year 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Price target increased by 10% to JP¥3,255

Calculating The Fair Value Of Terumo Corporation (TSE:4543)

Investors Still Waiting For A Pull Back In Terumo Corporation (TSE:4543)

Consensus EPS estimates increase by 11%

Price target increased by 7.4% to JP¥3,136

Terumo (TSE:4543) Has Announced A Dividend Of ¥22.00

New minor risk - Dividend sustainability

Upcoming dividend of JP¥22.00 per share

Terumo Corporation to Report Fiscal Year 2024 Results on May 14, 2024

Is Terumo (TSE:4543) Using Too Much Debt?

Price target increased by 7.3% to JP¥5,548

Terumo Corporation Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

Terumo Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024

Terumo Corporation, Annual General Meeting, Jun 26, 2024

Terumo Corporation to Report Q3, 2024 Results on Feb 07, 2024

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Terumo Corporation to Report Q2, 2024 Results on Nov 14, 2023

Upcoming dividend of JP¥22.00 per share at 1.1% yield

Terumo Corporation (TSE:4543) announces an Equity Buyback for 5,000,000 shares, representing 0.67% for ¥20,000 million.

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Terumo Corporation to Report Q1, 2024 Results on Aug 09, 2023

Terumo Corporation Announces Fiscal Year-End Dividend for the Fiscal Year Ended March 31, 2023, Payable on June 28, 2023; Provides Second Quarter-End Dividend Guidance for the Fiscal Year Ending March 31, 2024 and Provides Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2024

Full year 2023 earnings: EPS misses analyst expectations

Terumo Corporation, Annual General Meeting, Jun 27, 2023

Upcoming dividend of JP¥21.00 per share at 1.2% yield

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Terumo Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2023

Less than half of directors are independent

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Terumo Corporation Announces Dividend for the Second Quarter End of Fiscal Year 2023, Commences Dividend Payments on December 5, 2022; Provides Dividend Guidance for the Fiscal Year Ending March 31, 2023

Terumo Corporation to Report Q3, 2023 Results on Nov 10, 2023

Terumo Corporation to Report Q2, 2023 Results on Nov 10, 2022

Upcoming dividend of JP¥18.00 per share

Mitsui DM Sugar Holdings Co.,Ltd. (TSE:2109) agreed to acquire Enteral formula business of Terumo Corporation from Terumo Corporation (TSE:4543).

NUTRI Co.,Ltd. entered into an agreement to acquire Nutritional food and related product assets of Terumo Corporation.

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

Terumo Corporation Provides Dividend Guidance for the Second Quarter of Year Ending March 31, 2023

Less than half of directors are independent

Terumo Announces Change in Indication for Dexcom G6 CGM System in Japan

Full year 2022 earnings: EPS misses analyst expectations

Terumo Corporation (TSE:4543) announces an Equity Buyback for 15,000,000 shares, representing 1.98% for ¥50,000 million.

Less than half of directors are independent

Terumo Corporation to Report Fiscal Year 2022 Results on May 12, 2022

Upcoming dividend of JP¥16.00 per share

Third quarter 2022 earnings: EPS misses analyst expectations

Terumo Corporation, Annual General Meeting, Jun 22, 2022

Terumo Corporation Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2022

Second quarter 2022 earnings released: EPS JP¥29.22 (vs JP¥23.63 in 2Q 2021)

Upcoming dividend of JP¥15.00 per share

First quarter 2022 earnings released: EPS JP¥36.90 (vs JP¥18.57 in 1Q 2021)

Full year 2021 earnings released: EPS JP¥102 (vs JP¥114 in FY 2020)

Full year 2021 earnings released: EPS JP¥102 (vs JP¥114 in FY 2020)

Terumo Corporation Provides Dividend Guidance for the Year Ending March 2022

Upcoming dividend of JP¥14.00 per share